CB
CVS icon

Chemical Bank’s CVS Health CVS Stock Holding History

Chemical Bank’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$3.68M Sell
67,611
-4,877
-7% -$263K 0.42% 64
2019
Q1 		$3.91M Sell
72,488
-726
-1% -$44.8K 0.44% 62
2018
Q4 		$4.8M Buy
73,214
+33,763
+86% +$2.52M 0.59% 43
2018
Q3 		$3.11M Sell
39,451
-1,704
-4% -$122K 0.32% 76
2018
Q2 		$2.65M Buy
41,155
+2,045
+5% +$135K 0.28% 81
2018
Q1 		$2.43M Sell
39,110
-2,957
-7% -$212K 0.27% 87
2017
Q4 		$3.05M Sell
42,067
-3,256
-7% -$237K 0.33% 73
2017
Q3 		$3.69M Sell
45,323
-15,998
-26% -$1.27M 0.41% 63
2017
Q2 		$4.93M Sell
61,321
-1,219
-2% -$96.3K 0.54% 44
2017
Q1 		$4.91M Buy
62,540
+186
+0.3% +$14.8K 0.54% 45
2016
Q4 		$4.92M Buy
62,354
+2,423
+4% +$196K 0.56% 41
2016
Q3 		$5.33M Buy
59,931
+2,262
+4% +$214K 0.72% 32
2016
Q2 		$5.52M Buy
57,669
+1,261
+2% +$126K 0.76% 28
2016
Q1 		$5.85M Sell
56,408
-180
-0.3% -$17.5K 0.82% 26
2015
Q4 		$5.53M Buy
56,588
+561
+1% +$54.9K 0.77% 27
2015
Q3 		$5.41M Sell
56,027
-90
-0.2% -$9.46K 0.78% 28
2015
Q2 		$5.89M Sell
56,117
-1,081
-2% -$110K 0.78% 29
2015
Q1 		$5.9M Buy
57,198
+538
+0.9% +$54.4K 0.77% 29
2014
Q4 		$5.46M Buy
56,660
+3,554
+7% +$313K 0.71% 34
2014
Q3 		$4.23M Buy
53,106
+1,530
+3% +$121K 0.73% 30
2014
Q2 		$3.89M Buy
51,576
+105
+0.2% +$7.94K 0.66% 31
2014
Q1 		$3.85M Buy
51,471
+2,584
+5% +$183K 0.69% 32
2013
Q4 		$3.5M Buy
48,887
+1,040
+2% +$66.8K 0.62% 37
2013
Q3 		$2.72M Buy
47,847
+4,650
+11% +$277K 0.53% 46
2013
Q2 		$2.47M Buy
+43,197
New +$2.5M 0.49% 53

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Chemical Bank's CVS Position: Q2 2019 in Review

Chemical Bank reduced its CVS Health (CVS) stake by 6.7% in Q2 2019, selling an estimated $263K and leaving 67,611 shares worth $3.68M. The position accounts for 0.42% of the portfolio, ranked #64.

Chemical Bank first reported a position in CVS in Q2 2013 and has held it in 25 quarters since. The position peaked at $5.9M in Q1 2015. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Chemical Bank held 67,611 shares of CVS Health worth $3.68M as of Q2 2019.
  • Chemical Bank sold 4,877 CVS Health shares in Q2 2019, an estimated $263K.
  • CVS Health made up 0.42% of Chemical Bank's portfolio in Q2 2019, its #64 holding.
  • Chemical Bank first reported a position in CVS Health in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's CVS Health position peaked at $5.9M in Q1 2015.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.